The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Nucleic-acid therapeutics: basic principles and recent applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,892
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
RNA interference is mediated by 21- and 22-nucleotide RNAs
Elbashir, S. M., Lendeckel, W., & Tuschl, T. (2001) · Genes & Development · doi:10.1101/gad.862301 · Cited by 3,310
Zamore, P. D., Tuschl, T., Sharp, P. A., & Bartel, D. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80620-0 · Cited by 2,676
Ketting, R. F., Fischer, S. E. J., Bernstein, E., Sijen, T., Hannon, G. J., & Plasterk, R. H. A. (2001) · Genes & Development · doi:10.1101/gad.927801 · Cited by 1,852
Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAi
Hammond, S. M., Boettcher, S., Caudy, A. A., Kobayashi, R., & Hannon, G. J. (2001) · Science · doi:10.1126/science.1064023 · Cited by 1,580
A general purpose RNA-cleaving DNA enzyme
Santoro, S. W., & Joyce, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4262 · Cited by 1,541
Breaker, R. R., & Joyce, G. F. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90014-0 · Cited by 1,476
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate
Elbashir, S. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6877 · Cited by 1,449
Molecular thanatopsis: a discourse on the BCL2 family and cell death
Yang, E., & Korsmeyer, S. (1996) · Blood · doi:10.1182/blood.v88.2.386.bloodjournal882386 · Cited by 1,332
Morpholino Antisense Oligomers: Design, Preparation, and Properties
SUMMERTON, J., & WELLER, D. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.187 · Cited by 1,116
Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.
Stephenson, M. L., & Zamecnik, P. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.285 · Cited by 906
Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3026::aid-immu3026>3.0.co;2-h · Cited by 786
Mizuno, T., Chou, M. Y., & Inouye, M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1966 · Cited by 695
Degradation of mRNA in eukaryotes
Beelman, C. A., & Parker, R. (1995) · Cell · doi:10.1016/0092-8674(95)90326-7 · Cited by 651
Stable suppression of gene expression by RNAi in mammalian cells
Paddison, P. J., Caudy, A. A., & Hannon, G. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032652399 · Cited by 550
Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation.
Paterson, B. M., Roberts, B. E., & Kuff, E. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4370 · Cited by 536
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?
Yakubov, L. A., Deeva, E. A., Zarytova, V. F., Ivanova, E. M., Ryte, A. S., Yurchenko, L. V., & Vlassov, V. V. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6454 · Cited by 509
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
Webb, A., Cunningham, D., Cotter, F., Clarke, P., Di Stefano, F., Ross, P., Corbo, M., & Dziewanowska, Z. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11103-x · Cited by 489
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
Jansen, B., Wacheck, V, Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., & Pehamberger, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03207-4 · Cited by 482
Waters, J. S., Webb, A., Cunningham, D., Clarke, P. A., Raynaud, F., di Stefano, F., & Cotter, F. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1812 · Cited by 454
Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., & Fabbro, D. (1996) · Nature Medicine · doi:10.1038/nm0696-668 · Cited by 447
Mann, M. J., Whittemore, A. D., Donaldson, M. C., Belkin, M., Conte, M. S., Polak, J. F., Orav, E. J., Ehsan, A., Dell'Acqua, G., & Dzau, V. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)09405-2 · Cited by 402
Expanding small RNA interference
Tuschl, T. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-446 · Cited by 395
Bactericidal antisense effects of peptide–PNA conjugates
Good, L., Awasthi, S. K., Dryselius, R., Larsson, O., & Nielsen, P. E. (2001) · Nature Biotechnology · doi:10.1038/86753 · Cited by 391
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
Yacyshyn, B. R., Bowen-Yacyshyn, M. B., Jewell, L., Tami, J. A., Bennett, C. F., Kisner, D. L., & Shanahan, W. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70418-4 · Cited by 381
Real time detection of DNA⋅RNA hybridization in living cells
Sokol, D. L., Zhang, X., Lu, P., & Gewirtz, A. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11538 · Cited by 373
Self-citationRole of divalent metal ions in the hammerhead RNA cleavage reaction
Dahm, S. C., & Uhlenbeck, O. C. (1991) · Biochemistry · doi:10.1021/bi00103a011 · Cited by 366
Translational control of IS10 transposition
Simons, R. W., & Kleckner, N. (1983) · Cell · doi:10.1016/0092-8674(83)90401-4 · Cited by 363
Molecular mechanisms of action of antisense drugs
Crooke, S. T. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00148-7 · Cited by 358
Methia, N., Louache, F., Vainchenker, W., & Wendling, F. (1993) · Blood · doi:10.1182/blood.v82.5.1395.1395 · Cited by 350
Millan, C. L. B., Weeratna, R., Krieg, A. M., Siegrist, C.-A., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15553 · Cited by 345
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
Beltinger, C., Saragovi, H. U., Smith, R. M., LeSauteur, L., Shah, N., DeDionisio, L., Christensen, L., Raible, A., Jarett, L., & Gewirtz, A. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117860 · Cited by 312
Self-citationA Structural Basis for Recognition of A·T and T·A Base Pairs in the Minor Groove of B-DNA
Kielkopf, C. L., White, S., Szewczyk, J. W., Turner, J. M., Baird, E. E., Dervan, P. B., & Rees, D. C. (1998) · Science · doi:10.1126/science.282.5386.111 · Cited by 306
Dean, N. M., McKay, R., Condon, T. P., & Bennett, C. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34023-1 · Cited by 291
Reed, J. C., Stein, C. A., Subasinghe, C., Haldar, S., Croce, C. M., Yum, S., & Cohen, J. S. (1990) · PubMed · Cited by 289
p53 in hematologic malignancies
Imamura, J., Miyoshi, I., & Koeffler, H. (1994) · Blood · doi:10.1182/blood.v84.8.2412.2412 · Cited by 284
A Kinetic and Thermodynamic Framework for the Hammerhead Ribozyme Reaction
Hertel, K. J., Herschlag, D., & Uhlenbeck, O. C. (1994) · Biochemistry · doi:10.1021/bi00177a031 · Cited by 264
Selecting effective antisense reagents on combinatorial oligonucleotide arrays
Milner, N., Mir, K. U., & Southern, E. M. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-537 · Cited by 261
Stein, C. A. (1995) · Nature Medicine · doi:10.1038/nm1195-1119 · Cited by 255
Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
Bennett, C. F., Condon, T. P., Grimm, S., Chan, H., & Chiang, M. Y. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3530 · Cited by 252
Nucleic Acid Therapeutics: State of the Art and Future Prospects
Gewirtz, A. M., Sokol, D. L., & Ratajczak, M. Z. (1998) · Blood · doi:10.1182/blood.v92.3.712 · Cited by 250
Self-citationThe role of CpG dinucleotides in DNA vaccines
Krieg, A. M., Yi, A.-K., Schorr, J., & Davis, H. L. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01145-1 · Cited by 248
GALBRAITH, W. M., HOBSON, W. C., GICLAS, P. C., SCHECHTER, P. J., & AGRAWAL, S. (1994) · Antisense Research and Development · doi:10.1089/ard.1994.4.201 · Cited by 238
Yang, D., Lu, H., & Erickson, J. W. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00732-6 · Cited by 238
Antisense Oligonucleotides: Promise and Reality
Lebedeva, I., & Stein, C. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.403 · Cited by 236
Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides
Sierakowska, H., Sambade, M. J., Agrawal, S., & Kole, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12840 · Cited by 236
Cancer gene therapy: hard lessons and new courses
Vile, R. G., Russell, S. J., & Lemoine, N. R. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301084 · Cited by 231
Alternative Splicing and Neuritic mRNA Translocation Under Long-Term Neuronal Hypersensitivity
Meshorer, E., Erb, C., Gazit, R., Pavlovsky, L., Kaufer, D., Friedman, A., Glick, D., Ben-Arie, N., & Soreq, H. (2002) · Science · doi:10.1126/science.1066752 · Cited by 228
Bernstein, E., Denli, A. M., & Hannon, G. J. (2001) · PubMed · Cited by 224
Specific Double-Stranded RNA Interference in Undifferentiated Mouse Embryonic Stem Cells
Yang, S., Tutton, S., Pierce, E., & Yoon, K. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7807-7816.2001 · Cited by 224
Andrews, D. W., Resnicoff, M., Flanders, A. E., Kenyon, L., Curtis, M., Merli, G., Baserga, R., Iliakis, G., & Aiken, R. D. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2189 · Cited by 222
Dislodgment and Accelerated Degradation of Ras
Haklai, R., Weisz, M. G., Elad, G., Paz, A., Marciano, D., Egozi, Y., Ben-Baruch, G., & Kloog, Y. (1998) · Biochemistry · doi:10.1021/bi972032d · Cited by 194
Chi, K. N., Gleave, M. E., Klasa, R. J., Murray, N., Bryce, C. J., de Menezes, D. E. L., D’Aloisio, S., & Tolcher, A. W. (2001) · PubMed · Cited by 191
Fomivirsen – a phosphorothioate oligonucleotide for the treatment of CMV retinitis
de Smet, M. D., Meenken, C., & van den Horn, G. J. (1999) · Ocular Immunology and Inflammation · doi:10.1076/ocii.7.3.189.4007 · Cited by 187
Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries
Ho, S. P., Bao, Y., Lesher, T., Malhotra, R., Ma, L. Y., Fluharty, S. J., & Sakai, R. R. (1998) · Nature Biotechnology · doi:10.1038/nbt0198-59 · Cited by 186
Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease
Schreiber, S., Nikolaus, S., Malchow, H., Kruis, W., Lochs, H., Raedler, A., Hahn, E. G., Krummenerl, T., & Steinmann, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.24015 · Cited by 186
Triplex forming oligonucleotides: sequence-specific tools for gene targeting
Knauert, M. P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.20.2243 · Cited by 181
Nishikura, K. (2001) · Cell · doi:10.1016/s0092-8674(01)00581-5 · Cited by 176
Dean, N. S., McKay, R. A., Miraglia, L. J., Howard, R., Cooper, S. R., Giddings, J., Nicklin, P. L., Meister, L., Ziel, R., Geiger, T. M., et al. (1996) · PubMed · Cited by 175
Nemunaitis, J., Holmlund, J. T., Kraynak, M., Richards, D., Bruce, J., Ognoskie, N., Kwoh, T. J., Geary, R., Dorr, A., Von Hoff, D., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3586 · Cited by 173
Erythroid Cell-Specific mRNA Stability Elements in the α2-Globin 39 Nontranslated Region
Weiss, I. M., & Liebhaber, S. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2457 · Cited by 169
Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells
Mercatante, D. R., Bortner, C. D., Cidlowski, J. A., & Kole, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009256200 · Cited by 163
Lacerra, G., Sierakowska, H., Carestia, C., Fucharoen, S., Summerton, J., Weller, D., & Kole, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9591 · Cited by 159
Wong-Staal, F., Poeschla, E. M., & Looney, D. J. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.16-2407 · Cited by 158
Anderson, K., Fox, M., Brown‐Driver, V., Martin, M., & Azad, R. F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2004 · Cited by 153
Yuen, A. R., Halsey, J., Fisher, G. A., Holmlund, J. T., Geary, R. S., Kwoh, T. J., Dorr, A., & Sikic, B. I. (1999) · PubMed · Cited by 148
Juliano, R. L., Alahari, S. K., Yoo, H., Kole, R., & Cho, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1011958726518 · Cited by 145
Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics
Usman, N., & Blatt, L. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11631 · Cited by 137
Ehsan, A., Mann, M. J., Dell’Acqua, G., & Dzau, V. J. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.111204 · Cited by 137
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens
Jahrsdörfer, B., Hartmann, G., Racila, E. V., Jackson, W. J., Mühlenhoff, L., Meinhardt, G., Endres, S., Link, B. K., Krieg, A. Μ., & Weiner, G. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.1.81 · Cited by 137
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
Bishop, M. R., Iversen, P. L., Bayever, E., Sharp, J. G., Greiner, T. C., Copple, B. L., Ruddon, R., Zon, G., Spinolo, J., Arneson, M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1320 · Cited by 136
Monia, B. P., Sasmor, H. M., Johnston, J. F., Freier, S. M., Lesnik, E. A., Muller, M., Geiger, T. M., Altmann, K., Moser, H. E., & Fabbro, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15481 · Cited by 136
DNA Analogues with Nonphosphodiester Backbones
Nielsen, P. E. (1995) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.bb.24.060195.001123 · Cited by 126
Zamaratski, E., Pradeepkumar, P. I., & CHATTOPADHYAYA, J. B. (2001) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(01)00149-x · Cited by 126
Cunningham, C. C., Holmlund, J., Schiller, J. H., Geary, R. S., Kwoh, T. J., Dorr, A., & Nemunaitis, J. J. (2000) · PubMed · Cited by 126
Chkheidze, A. N., Lyakhov, D. L., Makeyev, A. V., Morales, J., Kong, J., & Liebhaber, S. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4572 · Cited by 125
Rudin, C. M., Holmlund, J. T., Fleming, G. F., Mani, S., Stadler, W. M., Schumm, L. P., Monia, B. P., Johnston, J. F., Geary, R. S., Yu, R. Z., et al. (2001) · PubMed · Cited by 114
Kinetics and Thermodynamics of Intermolecular Catalysis by Hairpin Ribozymes
Hegg, L. A., & Fedor, M. J. (1995) · Biochemistry · doi:10.1021/bi00048a027 · Cited by 112
Mulamba, G. B., Hu, A., Azad, R. F., Anderson, K., & Coen, D. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.971 · Cited by 112
Facilitating oligonucleotide delivery: helping antisense deliver on its promise.
Gewirtz, A. M., Stein, C. A., & Glazer, P. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3161 · Cited by 108
Self-citationInhibition of bcr-abl Oncogene Expression by Novel Deoxyribozymes (DNAzymes)
Wu, Y., Yu, L., McMahon, R., Rossi, J., Forman, S. J., & Snyder, D. (1999) · Human Gene Therapy · doi:10.1089/10430349950016573 · Cited by 107
Selecting optimal antisense reagents
Sohail, M., & Southern, E. M. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00081-8 · Cited by 104
Cunningham, C. C., Holmlund, J., Geary, R. S., Kwoh, T. J., Dorr, A., Johnston, J. F., Monia, B. P., & Nemunaitis, J. J. (2001) · Cancer · Cited by 101
Melton, D. W. (1994) · BioEssays · doi:10.1002/bies.950160907 · Cited by 98
Investigations of Antisense Oligonucleotides Targeted Against bcl-2 RNAs
Kitada, S., Miyashita, T., Tanaka, S., & REED, J. C. (1993) · Antisense Research and Development · doi:10.1089/ard.1993.3.157 · Cited by 94
Luo, Z., Macris, M. A., Faruqi, A. F., & Glazer, P. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160004997 · Cited by 93
Nestle, F. O., Mitra, R. S., Bennett, C. F., Chan, H., & Nickoloff, B. J. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12396876 · Cited by 93
A new and efficient DNA enzyme for the sequence-specific cleavage of RNA
Feldman, A. R., & Sen, D. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5058 · Cited by 93
Wraight, C. J., White, P. J., McKean, S. C., Fogarty, R. D., Venables, I., Liepe, I. J., Edmondson, S. R., & Werther, G. A. (2000) · Nature Biotechnology · doi:10.1038/75382 · Cited by 90
Bcl-2 family proteins: regulators of chemoresistance in cancer
Reed, J. C. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03551-6 · Cited by 86
Iversen, P. L. (2001) · PubMed · Cited by 85
Control of oncogene expression by antisense nucleic acids
Hélène, C. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(93)e0352-q · Cited by 84
Coudert, B. P., Anthoney, A., Fiedler, W., Droz, J., Dieras, V. C., Borner, M., Smyth, J. F., Morant, R., de Vries, M. J., Roelvink, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00286-6 · Cited by 83
Mixed Backbone Oligonucleotides: Improvement in Oligonucleotide-induced Toxicity In Vivo
Agrawal, S., & Zhao, Q. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.135 · Cited by 80
Luger, S. M., O’Brien, S. G., Ratajczak, J., Ratajczak, M. Z., Mick, R., Stadtmauer, E. A., Nowell̀, P. C., Goldman, J. M., & Gewirtz, A. M. (2002) · Blood · doi:10.1182/blood.v99.4.1150 · Cited by 77
Self-citationRibozymes, genomics and therapeutics
Rossi, J. J. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80001-5 · Cited by 65
Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis.
Sharma, H. W., Perez, J. R., Higgins-Sochaski, K. A., Hsiao, R.-X., & Narayanan, R. (1996) · PubMed · Cited by 62
Characterization of the nuclear binding sites of oligodeoxyribonucleotides and their analogs.
Clarenc, J. P., Lebleu, B., & Leonetti, J. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53363-9 · Cited by 58
The Hairpin Ribozyme: Discovery, Two-Dimensional Model, and Development for Gene Therapy
HAMPEL, A. E. (1997) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60032-x · Cited by 56
How to Design an Antisense Oligodeoxynucleotide Experiment: A Consensus Approach
Stein, C. A. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.129 · Cited by 54
Oligonucleotide Therapeutics: A Step Forward
Gewirtz, A. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1809 · Cited by 46
Self-citationSéréni, D., Tubiana, R., Lascoux‐Combe, C., Katlama, C., Taulera, O., Bourque, A. J., Cohen, A. S., Dvorchik, B. H., Martin, R. R., Tournerie, C., et al. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007552 · Cited by 44
Dean, N. M., McKay, R. A., Miraglia, L. J., Geigert, T., Müllert, M., Fabbro, D., & Bennett, C. F. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240623 · Cited by 42
Is irrelevant cleavage the price of antisense efficacy?
Stein, C. A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00053-4 · Cited by 38
Therapeutic Efficacy of an Adenovirus-Mediated Anti-H- ras Ribozyme in Experimental Bladder Cancer
Irie, A., Anderegg, B., Kashani–Sabet, M., OHKAWA, T., SUZUKI, T., Halks‐Miller, M., Curiel, D., & Kj, S. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.341 · Cited by 38
m RNA Stability and the Control of Gene Expression
Liebhaber, S. A. (2006) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0005972 · Cited by 38
Basilion, J. P., Schievella, A. R., Burns, E., Rioux, P. P., Olson, J. C., Monia, B. P., Lemonidis, K. M., Stanton, V. P., & Housman, D. E. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.359 · Cited by 34
Ribozymes in gene therapy of HIV-1
Macpherson, J. L. (1999) · Frontiers in bioscience · doi:10.2741/macpherson · Cited by 29
Eckstein, F. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240601 · Cited by 29
Defective c-myc and c-myb RNA turnover in acute myeloid leukemia cells
Baer, M., Augustinos, P., & Kinniburgh, A. J. (1992) · Blood · doi:10.1182/blood.v79.5.1319.1319 · Cited by 28
Brennscheidt, U., Riedel, D., Kölch, W., Bonifer, R., Brach, M. A., Ahlers, A., Mertelsmann, R., & Herrmann, F. (1994) · PubMed · Cited by 22
Anti-oncogene Ribozymes for Cancer Gene Therapy
Irie, A., Kijima, H., Ohkawa, T., Bouffard, D. Y., Suzuki, T., Curcio, L. D., Holm, P. S., Sassani, A., & Scanlon, K. J. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60141-6 · Cited by 21
Intracellular expression and function of antisense catalytic RNAs
Castanotto, D., Scherr, M., & Rossi, J. J. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)13025-3 · Cited by 19
Antisense Oligonucleotides as Modulators of Pre-mRNA Splicing
Sierakowska, H., Agrawal, S., & Kole, R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-215-5:223 · Cited by 15
Cited by
Activatable Photosensitizers for Imaging and Therapy
Lovell, J. F., Liu, T. W. B., Chen, J., & Zheng, G. (2010) · Chemical Reviews · doi:10.1021/cr900236h · Cited by 1,717
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains
Goodman, C. M., McCusker, C. D., Yilmaz, T., & Rotello, V. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049951i · Cited by 1,601
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Metadata
- Authors
- Opalinska, J. B., & Gewirtz, A. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-07
- Volume
- 1
- Issue
- 7
- Pages
- 503-514
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2059884965
- Cited by
- 537
- References
- 115
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.